Immix Biopharma Inc.

NASDAQ: IMMX · Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT

Immix Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.68M 17.51M 13.44M 17.64M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
20.42K 87.23K 6.72K n/a
Receivables
1.97M 1.17M 255.71K 25.72K
Inventory
n/a n/a n/a n/a
Other Current Assets
32.27K 44.58K 78.07K n/a
Total Current Assets
20.2M 19.79M 14.9M 18.19M
Property-Plant & Equipment
2.73M 50.18K 3.56K 5.7K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.75M 137.41K 10.28K 5.7K
Total Assets
22.95M 19.93M 14.91M 18.19M
Account Payables
5.39M 1.43M 143.07K 142.94K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
65.22K n/a n/a 50K
Other Current Liabilities
3.17M n/a n/a n/a
Total Current Liabilities
8.69M 3.72M 1.27M 202.04K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 475K n/a
Total Long-Term Liabilities
1.01M n/a 475K n/a
Total Liabilities
9.7M 3.72M 1.75M 202.04K
Total Debt
1.07M n/a n/a 50K
Common Stock
2.76K 2K 1.4K 1.32K
Retained Earnings
-75.02M -53.41M -37.99M -29.76M
Comprehensive Income
-1.06K 134.67K 87.02K 125.41K
Shareholders Equity
13.25M 16.41M 13.16M 17.99M
Total Investments
n/a n/a n/a n/a